Literature DB >> 8290591

Foot-and-mouth disease virus particles contain replicase protein 3D.

J F Newman1, P G Piatti, B M Gorman, T G Burrage, M D Ryan, M Flint, F Brown.   

Abstract

An antibody against the Escherichia coli-expressed RNA polymerase of foot-and-mouth disease virus (FMDV) reacts with the virus in ELISA and radioimmunoprecipitation experiments and with a protein of the disrupted virus particle in an immunoblot analysis. Treatment of the virus with trypsin, which cleaves capsid protein VP1 and a 56-kDa polypeptide present in trace amount in the particles, reduces the level of the reaction in ELISA and radioimmunoprecipitation and eliminates the immunoblot reaction. Electron microscopy showed that only approximately 20% of the virus particles reacted with the anti-polymerase antibody, whereas most reacted with an antibody against the immunodominant G-H loop of the virus. In the presence of ammonium ions, the expressed polymerase degrades the RNA of the virus into molecules sedimenting at approximately 12 S, indicating that it can act as a hydrolytic as well as a polymerizing enzyme. Moreover, the RNA in trypsin-treated virus particles is degraded when incubated at 37 degrees C, suggesting that the cleaved 56-kDa protein still possesses hydrolytic activity. In addition, the anti-polymerase antibody, which inhibits the polymerase activity of the E. coli-expressed protein, also partially inhibits the hydrolytic activity of the previously described endonuclease of the virus particle, suggesting that this enzyme is identical with the polymerase or forms part of it.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8290591      PMCID: PMC43023          DOI: 10.1073/pnas.91.2.733

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  THE USE OF ACETYLETHYLENEIMINE IN THE PRODUCTION OF INACTIVATED FOOT-AND-MOUTH DISEASE VACCINES.

Authors:  F BROWN; N S HYSLOP; J CRICK; A W MORROW
Journal:  J Hyg (Lond)       Date:  1963-09

2.  Studies with infective ribonucleic acid from tissues and cell cultures infected with the virus of foot-and-mouth disease.

Authors:  F BROWN; D L STEWART
Journal:  Virology       Date:  1959-04       Impact factor: 3.616

3.  Characterization of the minor polypeptides in the foot-and-mouth disease particle.

Authors:  D V Sangar; D J Rowlands; D Cavanagh; F Brown
Journal:  J Gen Virol       Date:  1976-04       Impact factor: 3.891

4.  Structure of the Mengo virion. I. Polypeptide and ribonucleate components of the virus particle.

Authors:  B R Ziola; D G Scraba
Journal:  Virology       Date:  1974-02       Impact factor: 3.616

5.  Structural proteins of foot-and-mouth disease virus.

Authors:  J Laporte; G Lenoir
Journal:  J Gen Virol       Date:  1973-08       Impact factor: 3.891

6.  Evidence for an internal antigen in foot-and-mouth disease virus.

Authors:  D J Rowlands; B Cartwright; F Brown
Journal:  J Gen Virol       Date:  1969-06       Impact factor: 3.891

7.  Foot-and-mouth disease virus-induced ribonucleic acid polymerase in baby hamster kidney cells.

Authors:  J Polatnick; R B Arlinghaus
Journal:  Virology       Date:  1967-04       Impact factor: 3.616

8.  The effect of heat on the structure of foot-and-mouth disease virus and the viral ribonucleic acid.

Authors:  F Brown; T F Wild
Journal:  Biochim Biophys Acta       Date:  1966-05-19

9.  A third antigenic component associated with foot-and-mouth disease infection.

Authors:  K M Cowan; J H Graves
Journal:  Virology       Date:  1966-11       Impact factor: 3.616

10.  Inactivation of foot-and-mouth disease virus vaccine strains by activation of virus-associated endonuclease.

Authors:  E A Scodeller; M A Lebendiker; M S Dubra; O A Crespo; O Basarab; J L La Torre; C Vasquez
Journal:  J Gen Virol       Date:  1984-09       Impact factor: 3.891

View more
  17 in total

1.  Foot-and-mouth disease virus and poliovirus particles contain proteins of the replication complex.

Authors:  J F Newman; F Brown
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  RNA binding properties of poliovirus subviral particles.

Authors:  C I Nugent; K Kirkegaard
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

3.  trans-encapsidation of a poliovirus replicon by different picornavirus capsid proteins.

Authors:  X Y Jia; M Van Eden; M G Busch; E Ehrenfeld; D F Summers
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

4.  Epitope mapping of monoclonal antibodies raised to recombinant Mengo 3D polymerase.

Authors:  H Duque; A C Palmenberg
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

5.  Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus.

Authors:  E Blanco; M Garcia-Briones; A Sanz-Parra; P Gomes; E De Oliveira; M L Valero; D Andreu; V Ley; F Sobrino
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

6.  Localization of binding site for encephalomyocarditis virus RNA polymerase in the 3'-noncoding region of the viral RNA.

Authors:  T Cui; A G Porter
Journal:  Nucleic Acids Res       Date:  1995-02-11       Impact factor: 16.971

7.  Identification of major histocompatibility complex restriction and anchor residues of foot-and-mouth disease virus-derived bovine T-cell epitopes.

Authors:  Wilhelm Gerner; Sabine E Hammer; Karl-Heinz Wiesmüller; Armin Saalmüller
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

8.  Functional coupling between replication and packaging of poliovirus replicon RNA.

Authors:  C I Nugent; K L Johnson; P Sarnow; K Kirkegaard
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

9.  A safe foot-and-mouth disease vaccine platform with two negative markers for differentiating infected from vaccinated animals.

Authors:  Sabena Uddowla; Jason Hollister; Juan M Pacheco; Luis L Rodriguez; Elizabeth Rieder
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

10.  Mouse neurovirulence determinants of poliovirus type 1 strain LS-a map to the coding regions of capsid protein VP1 and proteinase 2Apro.

Authors:  H H Lu; C F Yang; A D Murdin; M H Klein; J J Harber; O M Kew; E Wimmer
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.